Attenuating mutations in Venezuelan Equine Encephalitis virus
US5505947A · kind A · utility
63Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 1994 |
| Grant date | Apr 9, 1996 |
| Priority date | — |
| Expiry date | May 27, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel attenuating mutations of Venezuelan Equine Encephalitis (VEE) are disclosed. Further aspects of the invention include an infectious VEE virus transcript encoded by cDNA clones, infectious VEE virus particles, and pharmaceutical formulations containing such infectious particles. Also disclosed are recombinant VEE virus containing a heterologous RNA segment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.